Related Experiment Video
Updated: Sep 19, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Epidemiology and Characterization of Immunological Disorders in Children Diagnosed With Pneumococcal Invasive Disease
Chen Shahar1,2, Gilat Livni1,2,3, Nufar Marcus2,4
1Department of Pediatrics A, Schneider Children's Medical Center, Petah Tiqva, Israel.
Aim:
A substantial proportion of children hospitalized with invasive pneumococcal infection are subjected to immune evaluations, to detect immunological disorders (ID). The literature lacks thorough analysis of the necessity and effectiveness of these evaluations for previously healthy children with such infections. We aimed to examine the occurrence and characteristics of ID in children hospitalized with invasive pneumococcal disease (IPD), and to assess when immune investigations are most effective.
Methods:
In a retrospective study, we examined the immunological assessments and outcomes of children with IPD admitted during 2010-2023 to Schneider Children's Medical Center.
Results:
Out of 219 children with IPD, 144 previously healthy patients were included, with a mean age of 2.2 years and an average hospital stay of 9 days. Immunological evaluations, defined as any immune-related assessment, were performed in 94 patients (65.3%) and were not uniform across the cohort. ID were identified in 15 of 144 children (10.4%), corresponding to 15 of 94 evaluated patients (15.9%). Functional hyposplenism was the most frequent finding. No clinical or laboratory features reliably distinguished those with ID.
Conclusion:
Immunological evaluation should be considered in previously healthy children diagnosed with IPD. Functional hyposplenism should be considered when routine immunological evaluation is unrevealing; however, the role of universal spleen scintigraphy requires further prospective evaluation.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Atypical Pneumonia
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
